We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Epix To File For Bankruptcy If Restructuring Flops

Law360 (April 7, 2009, 12:00 AM EDT) -- Epix Pharmaceuticals Inc. says it may have to file for bankruptcy protection if it is unable to restructure its debt through an exchange offering of $100 million in convertible notes.

The Massachusetts-based biopharmaceutical company said Tuesday that it had commenced an exchange offer for senior convertible notes due in 2024 for shares of common stock and a cash payment.

Epix also said Tuesday that it had sold the U.S., Canadian and Australian rights for its magnetic resonance angiography agent, MS-325, to Lantheus Medical Imaging Inc. for...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.